Showing 1 - 20 results of 193 for search '"HIV-1"', query time: 0.09s Refine Results
  1. 1
  2. 2

    Artificial 64-Residue HIV-1 Enhancer-Binding Peptide Is a Potent Inhibitor of Viral Replication in HIV-1-Infected Cells by Mouhssin Oufir, Leslie R. Bisset, Stefan R. K. Hoffmann, Gongda Xue, Stephan Klauser, Bianca Bergamaschi, Alain Gervaix, Jürg Böni, Jörg Schüpbach, Bernd Gutte

    Published 2011-01-01
    “…Moreover, HIV-1 replication is inhibited by this peptide in HIV-1-infected CEM-GFP cells as revealed by HIV-1 p24 ELISA and real-time RT-PCR of HIV-1 RNA. …”
    Get full text
    Article
  3. 3

    Impact of Tat Genetic Variation on HIV-1 Disease by Luna Li, Satinder Dahiya, Sandhya Kortagere, Benjamas Aiamkitsumrit, David Cunningham, Vanessa Pirrone, Michael R. Nonnemacher, Brian Wigdahl

    Published 2012-01-01
    “…The human immunodeficiency virus type 1 (HIV-1) promoter or long-terminal repeat (LTR) regulates viral gene expression by interacting with multiple viral and host factors. …”
    Get full text
    Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Clinical Significance and Characterization of AZT-Resistant Strains of HIV-1 by Mark A Wainberg, Ronald Rooke, Michel Tremblay, XuGuang Li, Michael A Parniak, Qing Gao, Xiao-Jian Yao, Chris Tsoukas, JSG Montaner, M Fanning, J Ruedy

    Published 1991-01-01
    “…A number of laboratories have now independently confirmed that zidovudine (AZT)-resistant strains of human immunodeficiency virus type 1 (HIV-1) may be isolated from patients undergoing prolonged therapy with this drug. …”
    Get full text
    Article
  10. 10
  11. 11

    Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine by Sajib Chakraborty, Taibur Rahman, Rajib Chakravorty

    Published 2014-01-01
    “…This study was designed for the characterization the HIV-1 optimal CTL epitopes and their corresponding HLA alleles. …”
    Get full text
    Article
  12. 12

    The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy by Gabriela De Nardi Sanches-da-Silva, Luiza Fonseca Sales Medeiros, Fabio Mitsuo Lima

    Published 2019-01-01
    “…The HIV-1 virus (human immunodeficiency virus) affects 36.9 million people worldwide, with approximately 900000 deaths in 2017. …”
    Get full text
    Article
  13. 13
  14. 14
  15. 15

    Dynamical Analysis of Approximate Solutions of HIV-1 Model with an Arbitrary Order by Asma, Nigar Ali, Gul Zaman, Anwar Zeb, Vedat Suat Erturk, Il Hyo Jung

    Published 2019-01-01
    “…This article studies the dynamical behavior of the analytical solutions of the system of fraction order model of HIV-1 infection. For this purpose, first, the proposed integer order model is converted into fractional order model. …”
    Get full text
    Article
  16. 16

    T Cell Activation and Regulation of HIV-1: Same Effectors with Distinct Outcomes by Jean-François Fortin, Benoit Barbeau, Gilles A Robichaud, Michel J Tremblay

    Published 1999-01-01
    “…The molecular mechanisms that regulate the function of the immune system and human immunodeficiency virus type-1 (HIV-1) gene expression are diverse and complicated. …”
    Get full text
    Article
  17. 17

    Is PPAR𝛾 a Prospective Player in HIV-1-Associated Bone Disease? by Eoin J. Cotter, Patrick W. Mallon, Peter P. Doran

    Published 2009-01-01
    “…Currently infection with the human immunodeficiency virus-1 (HIV-1) is in most instances a chronic disease that can be controlled by effective antiretroviral therapy (ART). …”
    Get full text
    Article
  18. 18
  19. 19
  20. 20